Example: Heart Attack
Search clinical trials for: Antivenins
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Adherence to Medication Regime
- Anaemia,
- Colonization
- Congestive Heart Failure, Atrial Arrhythmia, Atrial Tachyarrhythmia, Atrial Fibrillation
- Depressive Disorder NOS
- Disseminated Sclerosis
- Lactational Amenorrhea Method
- Neurogenic Bladder Disorder
- Normal, Glaucoma & Retinal Pathology
- Recurrent Malignant Urinary System Neoplasm
- Spinal-surgery
- Trauma Splenic
- Trauma to the Spleen
- View Full List
Sponsors and Collaborators
- Abia State Ministry of Health
- Astellas Pharma Canada, Inc.
- Cinfa Biotech
- City University of Hong Kong
- European Research Council
- Fariba Nayeri
- Instituto de Radiomedicina (IRAM)
- Matthew Exline
- National Center for Advancing Translational Science (NCATS)
- New York University, New York, NY
- Pennine Care NHS Foundation Trust
- Sirona Dental Systems GmbH
- Trophea Development AB
- View Full List
Drug Interventions
- 40 µg/day E2 with NES 200® µg/day
- 99mTechnicium (sestamibi or tetrofosmin)
- ASTX727 LD
- Administration of Lotemax
- Axicabtagene Ciloleucel
- CNTO 136
- Doxycycline pre-operatively
- Omnitram Oral Tablet
- Polysaccharide Iron Complex 150 mg
- Saline (IV fluids)
- Simvastatin (≥40 mg)
- Thiazide
- ocriplasmin
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations